Literature DB >> 23915981

High risk of a large measles outbreak despite 30 years of measles vaccination in The Netherlands.

L Mollema1, G P Smits1, G A Berbers1, F R Van Der Klis1, R S Van Binnendijk1, H E De Melker1, S J M Hahné1.   

Abstract

Our aim was to assess progress towards measles elimination from The Netherlands by studying humoral measles immunity in the Dutch population. A population-based seroepidemiological study was conducted in 2006-2007 (N = 7900). Serum samples were analysed by a bead-based multiplex immunoassay. IgG levels ⩾0·2 IU/ml were considered protective. The overall seroprevalence in the Dutch population was 96%. However, 51% of socio-geographically clustered orthodox Protestant individuals aged <10 years were susceptible. Infants might be susceptible to measles between ages 4 months and 14 months, the age at which maternal antibodies have disappeared and the first measles, mumps, rubella (MMR) vaccination is administered, respectively. Waning of antibody concentrations was slower after the second MMR vaccination than after the first. The Netherlands is at an imminent risk of a measles outbreak in the orthodox Protestant minority. To prevent subsequent transmission to the general population, efforts to protect susceptible age groups are needed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23915981      PMCID: PMC9151141          DOI: 10.1017/S0950268813001532

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  32 in total

Review 1.  The theory of measles elimination: implications for the design of elimination strategies.

Authors:  Nigel J Gay
Journal:  J Infect Dis       Date:  2004-05-01       Impact factor: 5.226

2.  Measles antibody: reevaluation of protective titers.

Authors:  R T Chen; L E Markowitz; P Albrecht; J A Stewart; L M Mofenson; S R Preblud; W A Orenstein
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

3.  Immunosurveillance and the evaluation of national immunization programmes: a population-based approach.

Authors:  H E De Melker; M A Conyn-van Spaendonck
Journal:  Epidemiol Infect       Date:  1998-12       Impact factor: 2.451

4.  Measles serological survey in the Italian population: interpretation of results using mixture model.

Authors:  Maria Cristina Rota; Marco Massari; Giovanni Gabutti; Marcello Guido; Antonella De Donno; Marta Luisa Ciofi degli Atti
Journal:  Vaccine       Date:  2008-06-27       Impact factor: 3.641

5.  Use of mixture models in determining laboratory criterion for identification of seropositive individuals: application to parvovirus B19 serology.

Authors:  R A Parker; D D Erdman; L J Anderson
Journal:  J Virol Methods       Date:  1990-02       Impact factor: 2.014

6.  [The immunization status of patients registered with measles during the 1987-88 epidemic].

Authors:  H Bijkerk; M A Bilkert-Mooiman; H J Houtters
Journal:  Ned Tijdschr Geneeskd       Date:  1989-01-07

7.  Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey.

Authors:  C Amela; I Pachón; F de Ory
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

8.  Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan, 1995-1997.

Authors:  M S Lee; L J Chien; Y Y Yueh; C F Lu
Journal:  Vaccine       Date:  2001-09-14       Impact factor: 3.641

9.  Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study.

Authors:  J Mossong; L Putz; F Schneider
Journal:  Epidemiol Infect       Date:  2004-01       Impact factor: 2.451

10.  Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.

Authors:  B Christenson; M Böttiger
Journal:  Vaccine       Date:  1994-02       Impact factor: 3.641

View more
  11 in total

1.  Pre-vaccination evolution of antibodies among infants 0, 3 and 6months of age: A longitudinal analysis of measles, enterovirus 71 and coxsackievirus 16.

Authors:  Chuanxi Fu; Jichuan Shen; Long Lu; Yajing Li; Yimin Cao; Ming Wang; Sen Pei; Zhicong Yang; Qing Guo; Jeffrey Shaman
Journal:  Vaccine       Date:  2017-06-10       Impact factor: 3.641

2.  The challenges of sustaining measles elimination in Canada.

Authors:  N S Crowcroft
Journal:  Can Commun Dis Rep       Date:  2014-06-12

3.  Seropositivity of measles antibodies in the Israeli population prior to the nationwide 2018 - 2019 outbreak.

Authors:  Ravit Bassal; Victoria Indenbaum; Rakefet Pando; Tal Levin; Eilat Shinar; Doron Amichay; Mira Barak; Anat Ben-Dor; Adina Bar Haim; Ella Mendelson; Dani Cohen; Tamy Shohat
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

4.  Tolerability of Early Measles-Mumps-Rubella Vaccination in Infants Aged 6-14 Months During a Measles Outbreak in The Netherlands in 2013-2014.

Authors:  Nicoline A T van der Maas; T Woudenberg; S J M Hahné; H E de Melker
Journal:  J Infect Dis       Date:  2015-12-21       Impact factor: 5.226

5.  Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology.

Authors:  Tom Woudenberg; Rob S van Binnendijk; Elisabeth A M Sanders; Jacco Wallinga; Hester E de Melker; Wilhelmina L M Ruijs; Susan J M Hahné
Journal:  Euro Surveill       Date:  2017-01-19

6.  Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination.

Authors:  Sebastian Funk; Jennifer K Knapp; Emmaculate Lebo; Susan E Reef; Alya J Dabbagh; Katrina Kretsinger; Mark Jit; W John Edmunds; Peter M Strebel
Journal:  BMC Med       Date:  2019-09-25       Impact factor: 8.775

7.  Antibodies against measles and rubella virus among different age groups in Thailand: A population-based serological survey.

Authors:  Nasamon Wanlapakorn; Rujipat Wasitthankasem; Preeyaporn Vichaiwattana; Chompoonut Auphimai; Pornsak Yoocharoen; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PLoS One       Date:  2019-11-26       Impact factor: 3.240

8.  A Serosurvey Identifying Vulnerability to Measles in Health Care Workers. A Hospital-Based Prospective Seroprevalence Study.

Authors:  Jana Malinová; Marek Petráš; Alexander M Čelko
Journal:  Int J Environ Res Public Health       Date:  2020-06-12       Impact factor: 3.390

9.  Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands.

Authors:  Joske Hoes; Anna G C Boef; Mirjam J Knol; Hester E de Melker; Liesbeth Mollema; Fiona R M van der Klis; Nynke Y Rots; Debbie van Baarle
Journal:  Front Public Health       Date:  2018-07-27

10.  Seroepidemiology of Measles, Mumps and Rubella on Bonaire, St. Eustatius and Saba: The First Population-Based Serosurveillance Study in Caribbean Netherlands.

Authors:  Regnerus A Vos; Liesbeth Mollema; Rob van Binnendijk; Irene K Veldhuijzen; Gaby Smits; Alcira V A Janga-Jansen; Sharda Baboe-Kalpoe; Koen Hulshof; Fiona R M van der Klis; Hester E de Melker
Journal:  Vaccines (Basel)       Date:  2019-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.